Exp Ther Med. 2016 Jan;11(1):49-56. doi: 10.3892/etm.2015.2860. Epub 2015 Nov 12.

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis.

Experimental and therapeutic medicine

Yanli Liu, Jun Xiao, Xintian Shi, Guojun Hao, Qinkai Chen, Jing Zhou, Xin Wei

PMID: 26889216 PMCID: PMC4726883 DOI: 10.3892/etm.2015.2860

Abstract

Immunoglobulin A nephropathy (IgAN) is one of the most common types of primary glomerular disease. Immunosuppressive treatment for patients with IgAN remains controversial. The present meta-analysis aimed to assess the efficacy and safety of various immunosuppressive agents compared with steroids in patients with IgAN and moderate to severe proteinuria. PubMed, EMBASE, Cochrane Library, Chinese National Knowledge Infrastructure, Wanfang, Weipu, Chinese Biomedical Literature Database and Qinghuatongfang were searched for relevant randomized controlled trials (RCTs) published between 1990 and September 2013. All eligible studies (biopsy proven IgA nephropathy, use of immunosuppressive agents) measured urinary protein excretion and proteinuria remission. Data were analyzed with the random effects model using Review Manager. A total of 29 RCTs were included, involving 1,466 patients. Compared with steroids, immunosuppressive agents, including azathioprine [corrected] (AZA) [complete response (CR)/partial response (PR); relative risk (RR), 3.43; 95% confidence interval (CI) 1.92-6.12; P<0.0001], mycophenolate mofetil (MMF) (CR/PR; RR, 2.19; 95% CI, 1.25-3.85; P=0.006) and leflunomide (LET) (CR/PR; RR, 2.64; 95% CI, 1.80-3.86; P<0.00001) resulted in increased partial or complete proteinuria remission. Cyclophosphamide (CTX) resulted in a higher reduction of urinary protein excretion than steroids (SMD, 0.91; 95% CI, 0.41-1.41; P=0.0004)). Compared to CTX, LET showed higher effectiveness (CR/PR; RR, 2.01; 95% CI, 1.08-3.75; P=0.03) with a lower incidence of adverse events. The present meta-analysis, which is based on IgAN patients, suggested that AZA, MMF, LET and CTX are effective in reducing proteinuria levels, with acceptable side effects. Therefore, immunosuppressive agents may be considered promising therapeutic agents for the treatment of IgAN and should be investigated further in large sample size, high-quality studies.

Keywords: immunoglobulin A nephropathy; immunosuppressive agents; meta-analysis; proteinuria; steroids

References

1. Am J Kidney Dis. 1991 Jul;18(1):12-9 - PubMed
2. Zhonghua Yi Xue Za Zhi. 2002 Jun 25;82(12 ):796-801 - PubMed
3. Am J Kidney Dis. 2013 Sep;62(3):403-41 - PubMed
4. Nephrol Dial Transplant. 2008 Dec;23(12):3915-20 - PubMed
5. J Am Soc Nephrol. 2007 Dec;18(12):3177-83 - PubMed
6. J Am Soc Nephrol. 2012 Jun;23(6):1108-16 - PubMed
7. Kidney Int. 2010 Mar;77(6):543-9 - PubMed
8. Am J Kidney Dis. 2001 Oct;38(4):728-35 - PubMed
9. Nephrol Dial Transplant. 2005 Oct;20(10 ):2139-45 - PubMed
10. Am J Kidney Dis. 2000 Aug;36(2):227-37 - PubMed
11. Control Clin Trials. 1996 Feb;17(1):1-12 - PubMed
12. Am J Nephrol. 1990;10(2):137-47 - PubMed
13. J Urol Nephrol (Paris). 1968 Sep;74(9):694-5 - PubMed
14. Clin J Am Soc Nephrol. 2006 May;1(3):511-7 - PubMed
15. Kidney Int. 2004 May;65(5):1842-9 - PubMed

Publication Types

• Journal Article